14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.000001 $0.000001 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $0.000001 $0.000001
52 weeks $0.000001 $0.0850

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
Aug 19, 2019 $0.0359 $0.0458 $0.0359 $0.0421 6 160
Aug 16, 2019 $0.0400 $0.0434 $0.0351 $0.0434 9 183
Aug 15, 2019 $0.0376 $0.0458 $0.0375 $0.0420 61 624
Aug 14, 2019 $0.0472 $0.0472 $0.0341 $0.0376 12 980
Aug 13, 2019 $0.0425 $0.0433 $0.0369 $0.0433 55 546
Aug 12, 2019 $0.0400 $0.0436 $0.0400 $0.0429 12 824
Aug 09, 2019 $0.0444 $0.0449 $0.0444 $0.0449 20 055
Aug 08, 2019 $0.0371 $0.0435 $0.0370 $0.0433 36 472
Aug 07, 2019 $0.0447 $0.0447 $0.0351 $0.0393 108 124
Aug 06, 2019 $0.0425 $0.0425 $0.0425 $0.0425 5 087
Aug 05, 2019 $0.0458 $0.0463 $0.0400 $0.0446 6 532
Aug 02, 2019 $0.0400 $0.0498 $0.0400 $0.0427 102 852
Aug 01, 2019 $0.0400 $0.0495 $0.0400 $0.0450 39 197
Jul 31, 2019 $0.0519 $0.0519 $0.0430 $0.0484 76 651
Jul 30, 2019 $0.0450 $0.0490 $0.0400 $0.0490 107 568
Jul 29, 2019 $0.0413 $0.0500 $0.0400 $0.0475 136 370
Jul 26, 2019 $0.0401 $0.0488 $0.0351 $0.0413 144 692
Jul 25, 2019 $0.0400 $0.0489 $0.0400 $0.0489 18 610
Jul 24, 2019 $0.0428 $0.0489 $0.0400 $0.0480 28 094
Jul 23, 2019 $0.0438 $0.0595 $0.0310 $0.0487 116 398
Jul 22, 2019 $0.0480 $0.0600 $0.0438 $0.0535 108 421
Jul 19, 2019 $0.0530 $0.0581 $0.0460 $0.0480 20 400
Jul 18, 2019 $0.0500 $0.0599 $0.0500 $0.0599 51 901
Jul 17, 2019 $0.0570 $0.0599 $0.0510 $0.0586 26 560
Jul 16, 2019 $0.0569 $0.0570 $0.0500 $0.0570 10 003
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT